Boehringer-Ingelheim Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference The company's preliminary fourth quarter 2021 revenues grew 25 percent, year over year, while full-year revenues grew 39 percent. Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Roche's real-time PCR test detects defined mutations of the epidermal growth factor receptor gene in DNA from non-small cell lung cancer patients. BiomX, Boehringer Ingelheim Partner for Inflammatory Bowel Disease Biomarker Discovery Under the agreement, Israel’s BiomX will generate metagenomic data for gut microbiome samples from IBD patients using its XMarker biomarker discovery platform. TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium Keytruda and Ibrance demonstrate activity in molecularly defined populations, while a new cohort will explore Gilotrif in tumors with NRG1 fusions. Boehringer Ingelheim, GNA Biosolutions Partner on African Swine Fever Dx The firms are focusing on developing a rapid diagnostic test for African swine fever that can be used on GNA's portable MDx platform. Jan 18, 2018 Qiagen Gets FDA OK for Expanded Use of EGFR CDx for Lung Cancer Drug Oct 12, 2017 NIH Partners With Biopharmaceutical Firms on $215M Cancer Immunotherapy Research Initiative Jun 6, 2017 New Precision Oncology Options Emerge at ASCO in First-Line EGFR-Mutated, ALK-Positive Lung Cancer Premium Feb 8, 2017 Penn Medicine Gets $3M From Pharma Consortium for Diabetic Kidney Disease Study Oct 24, 2016 Precision Medicine Master Trial Aims to Tailor Therapy for Acute Myeloid Leukemia Patients Premium Apr 27, 2015 Survey Shows More NSCLC Patients Getting EGFR Testing, but Results Often Don't Inform Care Premium Nov 13, 2014 Gilotrif Survival Data for Del19 and L858R Patients has Implications for Treatment, Research Premium Oct 31, 2014 Boehringer Ingelheim Taps IDBS’ E-WorkBook Suite to Support R&D Premium Sep 24, 2014 With Boehringer Support, NCCN Awards Grants to Advance Evidence-based Development of Nintedanib Premium Nov 6, 2013 Drugmakers in Third Quarter Focus on Uptake of Newer Personalized Rx to Replace Older Versions Premium Sep 25, 2013 Boehringer Enlists Roche Subsidiary Ventana for Companion Dx Help Premium Sep 19, 2013 Ventana, Boehringer Ingelheim to Collaborate on CDx for Cancer Drugs Sep 4, 2013 After FDA Approval, Boehringer Ingelheim Launching PGx NSCLC Drug Gilotrif in US Premium Sep 3, 2013 Diaxonhit, Boehringer Ingelheim Collaborate on Cancer Therapeutic Targets Aug 14, 2013 Roche's HER2 Breast Cancer Segment Tops List of PGx Drug Sales in Q2 Premium Jul 18, 2013 Dx Focus: FDA Approves Qiagen Therascreen EGFR RGQ; Luminex xTAG CYP2D6 Kits Premium Jul 17, 2013 FDA Okays Boehringer's Gilotrif, Qiagen EGFR Test, Providing New PGx Options for Advanced NSCLC Premium Jul 12, 2013 FDA Approves Qiagen's Therascreen EGFR as CDx for Boehringer Ingelheim's NSCLC Drug May 15, 2013 Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx Premium Feb 15, 2013 Boehringer Ingelheim to Use ChemAxon's Cheminformatics Software for Drug Research Premium Load More Breaking News Myasthenia Gravis Study Identifies Genetic Risk Loci Affecting Acetylcholine Receptor Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA Illumina, National Cancer Center Japan Collaborate on Nasopharyngeal Cancer Study Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools SeqOne Genomics Closes €20M Series A Financing NeoGenomics Partners With Biomarker Collaborative to Provide Lung Cancer Resources The Scan For STEM Students to Stay New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports. To Inform or Not, To Know or Not The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information. Rapid Test Studies Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says. PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.